Manifestation of rheumatoid arthritis during subcutaneous allergen-specific immunotherapy with bee venom
Authors:
- Kamran GhoreschiKGKamran Ghoreschi
- Jörg FischerJFJörg Fischer
- Tilo BiedermannTBTilo Biedermann
- 1 December 2012
- journal article
- other
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 130 (6) , 1438-1439
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortalityJournal of Allergy and Clinical Immunology, 2012
- GA2LEN/EAACI pocket guide for allergen‐specific immunotherapy for allergic rhinitis and asthmaAllergy, 2010
- Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in miceArthritis & Rheumatism, 2007
- Specific immunotherapy-induced Sjögren’s syndromeRheumatology International, 2005
- Multiple Sclerosis after Allergen-Specific Immunotherapy and Influenza VaccinationEuropean Neurology, 2003
- Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patientsAllergy, 2003
- Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptorsNature, 2002